The Road to Diagnosis: MRI and Genetic Testing
At a Glance
BPAN can be difficult to recognize because early symptoms and MRI scans may be nonspecific or normal. Later MRI changes, including a substantia nigra halo, can support suspicion, but a pathogenic or likely pathogenic WDR45 variant confirms the diagnosis.
Getting to a diagnosis of Beta-propeller Protein-Associated Neurodegeneration (BPAN) is often a long and winding road. Because the condition is so rare and its features change over time, many families spend years searching for answers—a period often called the “diagnostic odyssey” [1]. In one study of 160 cases, the median delay between the first symptoms and a final diagnosis was more than six years [1].
Why BPAN is Often Misdiagnosed
In early childhood, the symptoms of BPAN are nonspecific, meaning they look like many other developmental conditions. Because of this, individuals are frequently given other diagnoses first:
- Cerebral Palsy (CP): Because BPAN often involves motor delays, low muscle tone (hypotonia), or stiffness (spasticity), it may initially be labeled as a non-progressive form of cerebral palsy [2][3].
- Rett Syndrome: Many show “Rett-like” features, such as repetitive hand-wringing, loss of purposeful hand use, and seizures [4][5]. If someone tests negative for the gene typically associated with Rett syndrome (MECP2), it should prompt a broader genetic evaluation rather than assuming BPAN is the only other option [6].
- Developmental and Epileptic Encephalopathy: Because seizures often start early and can be severe, the focus may initially be on the epilepsy alone rather than the underlying genetic cause [7][8].
The Evolution of MRI Findings
One reason diagnosis is delayed is that MRI (Magnetic Resonance Imaging) scans often look normal early in life [9]. Unlike some conditions that show clear signs from birth, the characteristic features of BPAN “evolve.” Note that repeat MRI timing is individualized; it should not delay genetic testing or be scheduled purely based on age without a clinical rationale.
Early Scans
In early childhood, brain iron is often completely absent on an MRI [9]. Instead, doctors may see subtle “clues” that are not specific to BPAN:
- Delayed Myelination: The protective coating on nerve fibers (myelin) may develop more slowly than usual [10].
- Thin Corpus Callosum: The “bridge” connecting the two halves of the brain may appear unusually thin [11].
- Brain Atrophy: Mild shrinking or loss of volume in the brain or cerebellum [10].
- Swelling: Occasionally, early scans show temporary swelling in specific brain regions like the substantia nigra or globus pallidus [9].
Later Scans
As the individual approaches adolescence or adulthood, changes can emerge that create a very specific pattern, helping to support the diagnosis [3][12].
- The T1 Substantia Nigra Halo: This is considered highly suggestive of BPAN. On a specific type of MRI scan (T1-weighted), doctors may see a bright, “halo-like” signal surrounding a dark, thin central band in the substantia nigra [13]. While distinctive, a pathogenic WDR45 variant—not the halo alone—is what definitively confirms the diagnosis [2].
- Globus Pallidus Iron: On certain sequences (like T2*), iron buildup can appear as dark areas on the scan [3].
- Comparison to PKAN: You may hear about another NBIA disorder called PKAN, which classically features an “eye-of-the-tiger” sign in the globus pallidus [14]. While that sign heavily favors PKAN, it is not universally present in all NBIA disorders. BPAN is more classically associated with the T1 halo [13][9].
The Definitive Test: Genetic Sequencing
While MRIs provide critical clues, the only way to definitively diagnose BPAN is through genetic testing [15]. A diagnosis is confirmed when a laboratory identifies a pathogenic or likely pathogenic variant in the WDR45 gene [16]. (A “Variant of Uncertain Significance” does not establish BPAN).
Testing, such as Whole Exome Sequencing (WES), can identify BPAN even before iron appears on an MRI [1][15]. However, WES can sometimes miss exon-level deletions, duplications, or low-level mosaicism. If clinical suspicion remains high after a negative WES result, geneticists may direct specialized deletion testing or broader genomic testing [9]. Identifying the WDR45 variant early allows families to stop the odyssey and focus on specialized care [15].
Common questions in this guide
What confirms a diagnosis of BPAN?
Can an MRI look normal when someone has BPAN?
Which MRI findings can point to BPAN?
What happens if whole exome sequencing is negative?
Why is BPAN sometimes mistaken for cerebral palsy or Rett syndrome?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Can you explain exactly which genetic test identified the WDR45 variant, and confirm if it is pathogenic?
- 2.If the first MRI was normal, what clinical changes should prompt us to schedule a follow-up scan?
- 3.How does the current presentation compare to 'classic' Rett syndrome, and why was BPAN the final diagnosis?
- 4.Are there specific MRI sequences, like SWI or T2*, that the radiologist should use to detect iron?
- 5.If genetic testing with WES had been negative, what would have been our next diagnostic step?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Quantitative retrospective natural history modeling of WDR45-related developmental and epileptic encephalopathy - a systematic cross-sectional analysis of 160 published cases.
Saffari A, Schröter J, Garbade SF, et al.
Autophagy 2022; (18(7)):1715-1727 doi:10.1080/15548627.2021.1990671.
PMID: 34818117 - 2
Beta-Propeller Protein-Associated Neurodegeneration (BPAN) Detected in a Child with Epileptic Spasms.
Kaleka G, McCormick ME, Krishnan A
Cureus 2019; (11(8)):e5404 doi:10.7759/cureus.5404.
PMID: 31632858 - 3
Phenotypic and Imaging Spectrum Associated With WDR45.
Adang LA, Pizzino A, Malhotra A, et al.
Pediatric neurology 2020; (109()):56-62 doi:10.1016/j.pediatrneurol.2020.03.005.
PMID: 32387008 - 4
WDR45 mutations in Rett (-like) syndrome and developmental delay: Case report and an appraisal of the literature.
Hoffjan S, Ibisler A, Tschentscher A, et al.
Molecular and cellular probes 2016; (30(1)):44-9.
PMID: 26790960 - 5
Beta Propellar Protein-Associated Neurodegeneration: A Rare Cause of Infantile Autistic Regression and Intracranial Calcification.
Yoganathan S, Arunachal G, Sudhakar SV, et al.
Neuropediatrics 2016; (47(2)):123-7 doi:10.1055/s-0035-1571189.
PMID: 26859818 - 6
Beta-propeller protein-associated neurodegeneration presenting Rett-like features: A case report and literature review.
Kano K, Yamanaka G, Muramatsu K, et al.
American journal of medical genetics. Part A 2021; (185(2)):579-583 doi:10.1002/ajmg.a.61993.
PMID: 33251766 - 7
Severe infantile onset developmental and epileptic encephalopathy caused by mutations in autophagy gene WDR45.
Carvill GL, Liu A, Mandelstam S, et al.
Epilepsia 2018; (59(1)):e5-e13 doi:10.1111/epi.13957.
PMID: 29171013 - 8
WDR45 variants as a major cause for a clinically variable intellectual disability syndrome from early infancy in females.
Abe-Hatano C, Inoue K, Takeshita E, et al.
Journal of medical genetics 2024; (61(12)):1119-1122 doi:10.1136/jmg-2024-110068.
PMID: 39467646 - 9
Expanding the Spectrum of Early Neuroradiologic Findings in β Propeller Protein-Associated Neurodegeneration.
Papandreou A, Soo AKS, Spaull R, et al.
AJNR. American journal of neuroradiology 2022; (43(12)):1810-1814 doi:10.3174/ajnr.A7693.
PMID: 36328404 - 10
Serial MRI alterations of pediatric patients with beta-propeller protein associated neurodegeneration (BPAN).
Kimura Y, Sato N, Ishiyama A, et al.
Journal of neuroradiology = Journal de neuroradiologie 2021; (48(2)):88-93 doi:10.1016/j.neurad.2020.04.002.
PMID: 32335071 - 11
Substantia Nigra Swelling and Dentate Nucleus T2 Hyperintensity May Be Early Magnetic Resonance Imaging Signs of β-Propeller Protein-Associated Neurodegeneration.
Russo C, Ardissone A, Freri E, et al.
Movement disorders clinical practice 2019; (6(1)):51-56 doi:10.1002/mdc3.12693.
PMID: 30746416 - 12
Consensus clinical management guideline for beta-propeller protein-associated neurodegeneration.
Wilson JL, Gregory A, Kurian MA, et al.
Developmental medicine and child neurology 2021; (63(12)):1402-1409 doi:10.1111/dmcn.14980.
PMID: 34347296 - 13
Early-Onset Parkinsonism and Halo Sign: Beta-propeller Proteinassociated Neurodegeneration.
Samanta D, Ramakrishnaiah R
Journal of pediatric neurosciences 2020; (15(3)):325-327 doi:10.4103/jpn.JPN_62_20.
PMID: 33531960 - 14
A novel WDR45 mutation in a patient with β-propeller protein-associated neurodegeneration.
Wynn DP, Pulst SM
Neurology. Genetics 2017; (3(1)):e124 doi:10.1212/NXG.0000000000000124.
PMID: 27957548 - 15
Functional mRNA analysis reveals aberrant splicing caused by novel intronic mutation in WDR45 in NBIA patient.
Willoughby J, Duff-Farrier C, Desurkar A, et al.
American journal of medical genetics. Part A 2018; (176(5)):1049-1054 doi:10.1002/ajmg.a.38656.
PMID: 29681108 - 16
Early onset developmental delay and epilepsy in pediatric patients with WDR45 variants.
Chen H, Qian Y, Yu S, et al.
European journal of medical genetics 2019; (62(2)):149-160 doi:10.1016/j.ejmg.2018.07.002.
PMID: 29981852
This page explains MRI findings and WDR45 testing in BPAN for informational purposes only and does not constitute medical advice. Your neurologist and genetics team should interpret individual results and recommend next steps.
Get notified when new evidence is published on Beta-propeller protein-associated neurodegeneration.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.